| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |